首页> 外文期刊>Neurobiology of Aging: Experimental and Clinical Research >Effects of memantine on hippocampal long-term potentiation, gamma activity, and sensorimotor gating in freely moving rats
【24h】

Effects of memantine on hippocampal long-term potentiation, gamma activity, and sensorimotor gating in freely moving rats

机译:Memantine对自由移动大鼠海马长期增强,γ活性和传感器门控的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Memantine, an uncompetitive N-methyl-D-aspartate receptor antagonist, is used for treatment of patients with Alzheimer's disease. The mechanisms of memantine in relieving cognitive and behavioral symptoms are unclear, and this study attempts to elucidate its action on network and synaptic functions of the hippocampus. The effects of memantine on electrographic activity and hippocampal long-term potentiation (LTP) were investigated in freely moving rats. Basal dendritic excitation on hippocampal CA1 pyramidal cells showed a robust LTP after theta-frequency primed bursts, and the LTP was higher after 5-10 mg/kg intraperitoneal (ip) memantine pretreatment, as compared with saline pretreatment. Injection of scopolamine (5 mg/kg ip) before memantine failed to block the LTP-enhancing effect of memantine. Memantine as compared with saline pretreatment did not affect the LTP after an after-discharge induced by high-frequency (200-Hz) train stimulation. Memantine (5 or 10 mg/kg ip) significantly enhanced gamma oscillations in the hippocampal local field potentials of 40-100 Hz during walking and awake immobility. Memantine at 10 mg/kg ip, but not at 5 mg/kg ip, increased prepulse inhibition of the acoustic startle response, while both 5 and 10 mg/kg ip memantine enhanced the acoustic startle response as compared with saline-injected rats. These electrophysiological and behavioral effects of memantine are unique among N-methyl-D-aspartate receptor antagonists but are consistent with memantine's effects in improving cognitive and sensorimotor functions of Alzheimer's patients. (C) 2015 Elsevier Inc. All rights reserved.
机译:Memantine,一种非竞争力的N-甲基-D-天冬氨酸受体拮抗剂,用于治疗阿尔茨海默病患者。致癌认知和行为症状在致明症中的致病机制尚不清楚,这项研究试图阐明其对海马网络和突触功能的作用。在自由移动的大鼠中研究了Memantine对拍摄活性和海马长期增强(LTP)的影响。在海马CA1锥体细胞上的基础树突激发术后稳健的LTP在蒸频灌注后,腹膜内(IP)腹膜内(IP)留胡植的预处理后更高,与盐水预处理相比,LTP更高。在Memantine之前注射汽油胺(5mg / kg IP)未能阻断Memantine的LTP增强效果。与盐水预处理相比,Memantine在高频(200 Hz)火车刺激引起的后放电后不会影响LTP。在步行和清醒期间,Memantine(5或10mg / kg IP)在海马局部局部电位中显着增强了40-100 Hz的海马局部电位。 Memantine以10mg / kg IP,但不为5mg / kg IP,增加了对声爆炸反应的预先抑制,而5和10mg / kg IP Memantine与盐水注入的大鼠相比增强了声辐射响应。 Memantine的这些电生理学和行为效应在N-甲基-D-天冬氨酸受体拮抗剂中是独特的,但与Memantine的作用一致地改善阿尔茨海默氏症患者的认知和传感器功能。 (c)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号